HCID 9822354, compound → HCID 54053863, compound
Reaction equation
[O:1]1[C:6]2[C:7]3[CH2:13][CH2:12][CH2:11][C:8]=3[CH:9]=[CH:10][C:5]=2[CH2:4][CH2:3][CH:2]1[CH2:14][NH:15][CH2:16][CH2:17][CH2:18][NH:19][C:20]1[N:25]=[CH:24][CH:23]=[CH:22][N:21]=1.[O:26]1C(CNCCCNC2N=CC=CN=2)CCC2C=CC3C(OCCC=3)C1=2.O1C(CNCCCNC2N=CC=CN=2)CCC2C=CC3CCCCC=3C1=2.N1CCN=C1NCCCNCC1CCC2C=CC3CCCC=3C=2O1.O1C(CNCCCNC2NCCCN=2)CCC2C=CC3CCCOC=3C1=2.O1C2C3CCCC=3C=CC=2CCC1CNCCCNC1NCCCN=1.O1C2C3OC(CNCCCNC4NCCCN=4)CCC=3C=CC=2OCC1.O1C(CNCCCNC2NCCCN=2)CCC2C=CC3CCCCC=3C1=2.FC1C=C(C=CC(OC)=O)C2OC(CNCCCNC3N=CC=CN=3)CCC=2C=1.FC1C=C(C2OC=CC=2)C2OC(CNCCCNC3N=CC=CN=3)CCC=2C=1.FC1C=C(C2SC=CC=2)C2OC(CNCCCNC3NCCCN=3)CCC=2C=1.O1C2C=CC=CC=2CCC1CNCCCNC1CCCCN=1.O1C2C=CC=CC=2CCC1CNCCCNC1C=CN=C(NC)N=1>>[O:1]1[CH:2]([CH2:14][NH:15][CH2:16][CH2:17][CH2:18][NH:19][C:20]2[N:25]=[CH:24][CH:23]=[CH:22][N:21]=2)[CH2:3][CH2:4][C:5]2[CH:10]=[CH:9][C:8]3[CH2:11][CH2:12][CH2:13][O:26][C:7]=3[C:6]1=2Participants
Reactant 13
Product 1
Procedure
N-[(2,3,4,7,8,9-hexahydrocyclopenta[h]-1-benzopyran-2-yl)methyl]-N'-2-pyrimidinyl-1,3-propanediamine; (±)-N-[(2,3,4,8,9,10-hexahydrobenzo[2,1-b:3,4-b']dipyran-2-yl)methyl]-N'-2-pyrimidinyl-1,3-propane diamine; N-[(3,4,7,8,9,10-hexahydro-2H-naphtho[1,2-b]pyran-2-yl)methyl]-N'-2-pyrimidinyl-1,3-propanediamine; N-(4,5-dihydro-1H-imidazol-2-yl)-N'-[(2,3,4,7,8,9-hexahydrocyclopenta[h]-1-benzopyran-2-yl)methyl]-1,3-propanediamine; N-[(2,3,4,7,8,9-hexahydrobenzo[2,1-b:3,4-b']dipyran-2-yl)methyl]-N'-(1,4,5,6-tetrahydro-2-pyrimidinyl)-1,3-propanediamine; N-[(2,3,4,7,8,9-hexahydrocyclopenta[h]-1-benzopyran-2-yl)methyl]-N'-(1,4,5,6-tetrahydro-2-pyrimidinyl)-1,3-propanediamine; N-[(2,3,7,8-tetrahydro-9H-pyrano[2,3-f]-1,4-benzodioxin-9-yl)methyl]-N'-(1,4,5,6-tetrahydro-2-pyrimidinyl)-1,3-propanediamine; N-[(3,4,7,8,9,10-hexahydro-2H-naphtho[1,2-b]pyran-2-yl)methyl]-N'-(1,4,5,6-tetrahydro-2-pyrimidinyl)-1,3-propanediamine; methyl 3-[6-fluoro-3,4-dihydro-2-[[[3-(2-pyrimidinylamino)propyl]amino]methyl]-2H-1-benzopyran-8-yl]-2-propenoate; N-[[6-fluoro-8-(2-furanyl)-3,4-dihydro-2H-1-benzopyran-2-yl]methyl]-N'-2-pyrimidinyl-1,3-propanediamine; N-[[6-fluoro-3,4-dihydro-8-(2-thienyl)-2H-1-benzopyran-2-yl]methyl]-N'-(1,4,5,6-tetrahydro-2-pyrimidinyl)-1,3-propanediamine; N-[(3,4-dihydro-2H-1-benzopyran-2-yl)methyl]-N'-(3,4,5,6-tetrahydro-2-pyridinyl)-1,3-propanediamine; N4 -[3-[[(3,4-dihydro-2H-1-benzopyran-2-yl)methyl]amino]propyl]-N2-methyl-2,4-pyrimidinediamine, the pharmaceutically acceptable acid addition salts thereof and the stereochemically isomeric forms thereof.
Sources & evidence
- ORD record
- ord-dfa0edb2aff843d9a66ff9903a5c9e72
- Source dataset
- uspto-grants-2000_08
- Patent number
- US06100268
Reaction notes
Loading…